Global Blood Ther (GBT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Sales | 71,550 | 55,160 | 56,099 | 52,052 | 47,555 |
| Cost of Goods | 1,413 | 1,055 | 1,154 | 830 | 748 |
| Gross Profit | 70,137 | 54,105 | 54,945 | 51,222 | 46,807 |
| Operating Expenses | 146,276 | 127,421 | 138,061 | 119,346 | 113,625 |
| Operating Income | -75,726 | -73,261 | -82,962 | -67,294 | -66,070 |
| Interest Expense | 8,402 | 8,205 | 4,392 | 3,709 | 3,677 |
| Other Income | 1,850 | 214 | 97 | 15 | 185 |
| Pre-tax Income | -82,278 | -81,252 | -87,257 | -70,988 | -69,562 |
| Income Tax | 192 | 171 | 324 | N/A | 30 |
| Net Income Continuous | -82,470 | -81,423 | -87,581 | -70,988 | -69,592 |
| Net Income | $-82,470 | $-81,423 | $-87,581 | $-70,988 | $-69,592 |
| EPS Basic Total Ops | -1.26 | -1.26 | -1.35 | -1.13 | -1.12 |
| EPS Basic Continuous Ops | -1.26 | -1.26 | -1.36 | -1.13 | -1.12 |
| EPS Diluted Total Ops | -1.26 | -1.26 | -1.35 | -1.13 | -1.12 |
| EPS Diluted Continuous Ops | -1.26 | -1.26 | -1.36 | -1.13 | -1.12 |
| EPS Diluted Before Non-Recurring Items | -1.26 | -1.26 | -1.36 | -1.13 | -1.12 |
| EBITDA(a) | $-73,440 | $-70,889 | $-80,666 | $-65,090 | $-63,865 |